Consequently, the distinction of angiocentric gliomas from what the WHO terms "diffuse astrocytomas, MYB/MYBL1-altered" could be revisited at the time of the next revision of the CNS WHO classification. Here, MYBL1 is linked to diffuse astrocytoma.